News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Australia's government shrinks investor tax perks, replacing the 50% CGT discount with an indexation-linked measure.
  • Commonwealth Bank added A$200 million to provisions, shares plunged over 10%, dragging Australian banking stocks.
  • EQT launched a takeover bid for Kakaku, lifting the stock about 17% to its highest since 2021.
  • Siemens Q2 orders rose 11% but sales were flat and industrial profit fell 8%, missing forecasts.
  • Argentina increased maritime surveillance after a near 50% rise in Chinese-flagged fishing vessels near its waters.
  • Japan's three largest banks will onboard Anthropic's Mythos AI within two weeks, raising cybersecurity and regulatory concerns.
  • Bank of Thailand held its policy rate at 1.00% and signalled patience as near-term inflation risks rise.

Latest Articles

Sarepta Shares Slide After Steep Drop in Elevidys Sales

Sarepta Shares Slide After Steep Drop in Elevidys Sales

Sarepta Therapeutics saw its stock tumble in premarket trading after reporting a sharp decrease in first-quarter revenue from its gene therapy Elevidys. The company attributed the decline in sales volume to an updated label that limits treatment to patients who can walk - a change issued by the FDA following safety concerns and patient deaths. Over…

Citi Shares Slide After Investor Day Lays Out 2026-2031 ROTCE Targets

Citi Shares Slide After Investor Day Lays Out 2026-2031 ROTCE Targets

Citigroup shares fell 3.1% in premarket trading after the bank's investor day presented a phased ROTCE plan: 10%-11% for 2026, 11%-13% for 2027-2028 (excluding notable items), and a medium-term 14%-15% range for 2029-2031. Analysts said the near-term trajectory and clarity on capital returns will be closely watched by investors.

Regency Centers Declares Quarterly Dividends

Regency Centers Declares Quarterly Dividends

Regency Centers Corporation declared quarterly cash dividends for its common stock as well as Series A and Series B preferred stocks. The common stock dividend of $0.755 per share will be paid on July 2, 2026, and dividends for preferred stocks will be paid on July 31, 2026. Regency Centers is a leading national real estate investment trust focusin…

Inuvo to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 14th at 4:15 P.M. ET

Inuvo to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 14th at 4:15 P.M. ET

Inuvo, Inc., an AI-driven advertising technology company, announced it will hold a conference call on May 14, 2026, to discuss its financial results for the first quarter ended March 31, 2026, and provide a business update. The call details and replay information were provided, highlighting Inuvo's patented IntentKey AI technology for media audienc…

Swiss inflation rises to 18-month high as fuel prices jump

Swiss inflation rises to 18-month high as fuel prices jump

Swiss consumer prices climbed 0.6% year-on-year in April, up from 0.3% in March and the highest rate since December 2024, driven mainly by a 17% increase in petroleum product prices. On a monthly basis, overall prices rose 0.3% as petrol, diesel and heating oil became more expensive. Air travel and international holiday costs rose, while hotel stay…

Tokyo stepped into FX markets during Golden Week to steady yen as 160 level loomed

Tokyo stepped into FX markets during Golden Week to steady yen as 160 level loomed

A former central bank official who took part in market interventions a decade ago says Japanese authorities likely entered currency markets over the Golden Week holidays to curb a potential sharp decline in the yen if it fell below the psychologically charged 160-per-dollar mark. Officials appear to have acted to back up public comments and to coun…

VCI Global Enters Binding Term Sheet for Strategic Investment in Brazil Gold Asset, Advancing Integration of Physical Gold into RWA and Digital Asset Treasury Strategy

VCI Global Enters Binding Term Sheet for Strategic Investment in Brazil Gold Asset, Advancing Integration of Physical Gold into RWA and Digital Asset Treasury Strategy

VCI Global Limited has entered a binding term sheet to make a strategic investment in a gold mining asset in Brazil with estimated gold resources of approximately 59.9 tonnes. The company plans to initially invest and act as EPC partner, retaining an option to increase ownership to 51%. This aligns with VCI Global's strategy to integrate physical c…

ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals

ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals

ENvue Medical has secured a three-year renewal of its purchasing agreement with a Group Purchasing Organization representing one of the largest non-profit health systems in the United States, which operates more than 90 hospitals. This renewal guarantees hospitals within the network continued access to ENvue's Navigation Platform, facilitating easi…

Play AWS’s Agentic AI Wave: A Tactical Long on Amazon

Play AWS’s Agentic AI Wave: A Tactical Long on Amazon

Agentic AI workloads are moving from research pilots to committed production deals. Amazon’s scale in cloud, services and customer contracts positions AWS to capture recurring, high-margin revenue as enterprises deploy agentic systems. We outline a long trade with entry, stop and target and explain the fundamental and technical picture supporting t…

Inseego Names Koroush Saraf Chief Product Officer to Drive Innovation and Next Phase of Product Strategy

Inseego Names Koroush Saraf Chief Product Officer to Drive Innovation and Next Phase of Product Strategy

Inseego Corp. has appointed Koroush Saraf as Chief Product Officer to spearhead product strategy and growth amid expanding scale and capabilities, including after the acquisition of Nokia's Fixed Wireless Access business. Saraf brings extensive experience in SD-WAN, cloud security, LTE, 5G, and edge AI infrastructure, aligning with Inseego's focus …

Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury

Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury

Silo Pharma announced a strategic initiative exploring ibogaine-based therapeutics for traumatic brain injury (TBI) and related neuropsychiatric disorders, filing a provisional patent for compositions using ibogaine. This effort aligns with recent FDA breakthroughs and reflects promising clinical data showing symptom reduction and brain structural …

Alpha Modus and SurgePays Sign 25,000-Activation Pilot to Launch Alpha Cash Across SurgePays' Prepaid Wireless and Convenience-Store Distribution Network

Alpha Modus and SurgePays Sign 25,000-Activation Pilot to Launch Alpha Cash Across SurgePays' Prepaid Wireless and Convenience-Store Distribution Network

Alpha Modus Holdings and SurgePays announced a multi-year commercial agreement to integrate and distribute the Alpha Cash mobile wallet through SurgePays' prepaid wireless and convenience-store channels. The partnership targets the large underbanked U.S. consumer market by embedding the wallet within existing onboarding and retail platforms, commen…

Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline

Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline

Scienture Holdings, Inc. has secured $11 million in non-dilutive debt financing through promissory notes to support the commercialization of its FDA-approved products, Arbli™ for hypertension and REZENOPY™ for opioid overdose treatment, as well as to advance its diverse R&D pipeline. The financing aims to strengthen Scienture's capital position and…

Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings

Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings

Ardelyx, Inc. announced positive long-term safety data of its FDA-approved drug XPHOZAH (tenapanor) for managing serum phosphorus in chronic kidney disease patients on dialysis. Data from two clinical trials reflect no significant changes in serum electrolytes other than phosphate, nutritional markers, body mass, or blood pressure, reinforcing the …

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality

NRx Pharmaceuticals has received FDA clearance to begin a phase 2/3 clinical trial testing NRX-101 combined with Robotic-enabled Transcranial Magnetic Stimulation (TMS) versus placebo in patients with treatment-resistant depression and suicidality. The trial aims to enroll 240+ patients at academic, military, and clinical sites across the US. This …

vTv Therapeutics to Participate in Upcoming May Investor Conferences

vTv Therapeutics to Participate in Upcoming May Investor Conferences

vTv Therapeutics announced management's participation in two upcoming investor conferences in May 2026, highlighting their late-stage clinical development of cadisegliatin, an oral adjunctive therapy for type 1 diabetes currently in Phase 3 trials. The company plans to webcast fireside chats providing updates on their pipeline. Cadisegliatin has re…